Depth increases in lineup of breast imaging options

January 1, 2009 Diagnostic Imaging. Vol. 31 No. 1 Depth increases in lineup of breast imaging options Horizon of breast cancer detection extends to tomosynthesis and positron emission mammography By Rebekah Moan with additional reporting by Philip Ward, David Ma, and Kristin Minogue Breast imaging remained a strong point of scientific research at the 2008 RSNA meeting, with breast MRI playing a starring role but sharing the limelight with tomosynthesis, position emission mammography, and breastspecific gamma imaging. Nola Hylton, Ph.D., and colleagues showed preliminary results from American College of Radiology Imaging Network trial 6657. It found that MRI measures residual breast cancer disease more accurately than clinical exams or mammography.

See full article and related articles at DiagnosticImaging.com
This article was republished with permission from CMPMedica, LLC